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Objectives The aim of this study was to examine the association of central (waist circumference [WC] and waist-hip
ratio [WHR]) and total obesity (body mass index [BMI]) measures with mortality in coronary artery disease
(CAD) patients.
Background The question of which measure of obesity better predicts survival in patients with CAD is controversial.
Methods We searched OVID/Medline, EMBASE, CENTRAL, and Web of Science from 1980 to 2008 and asked experts in
the field for unpublished data meeting inclusion criteria, in which all subjects had: 1) CAD at baseline; 2) mea-
sures of WC or WHR; 3) mortality data; and 4) a minimum follow-up of 6 months.
Results From 2,188 studies found, 6 met inclusion criteria. We obtained individual subject data from 4, adding unpub-
lished data from a cardiac rehabilitation cohort. A variable called “central obesity” was created on the basis of
tertiles of WHR or WC. Cox-proportional hazards were adjusted for age, sex, and confounders. The final sample
consisted of 15,923 subjects. There were 5,696 deaths after a median follow-up of 2.3 (interquartile range 0.5
to 7.4) years. Central obesity was associated with mortality (hazard ratio [HR]: 1.70, 95% confidence interval
[CI]: 1.58 to 1.83), whereas BMI was inversely associated with mortality (HR: 0.64, 95% CI: 0.59 to 0.69). Cen-
tral obesity was also associated with higher mortality in the subset of subjects with normal BMI (HR: 1.70, 95%
CI: 1.52 to 1.89) and BMI 30 kg/m2 (HR: 1.93, 95% CI: 1.61 to 2.32).
Conclusions In subjects with CAD, including those with normal and high BMI, central obesity but not BMI is directly associ-
ated with mortality. (J Am Coll Cardiol 2011;57:1877–86) © 2011 by the American College of Cardiology
Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.11.058Obesity is a worldwide epidemic (1), and its prevalence
among children, adolescents, and adults has increased
markedly (2). Although the rates of obesity seem to have
plateaued in recent years, its prevalence continues to be
significantly elevated among U.S. adults (32.2% in men,
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Central Obesity and Mortality in CAD May 10, 2011:1877–86Historically, the relationship
between obesity and coronary ar-
tery disease (CAD) has been at-
tributed to cardiovascular risk
factors associated with obesity.
However, longitudinal studies
suggest that obesity is an inde-
pendent predictor of CAD (5,6).
Alternatively, studies have also
reported an inverse association
between body mass index (BMI)
and mortality in subjects with
CAD. This has been called the
“obesity paradox” (7,8) and has been attributed to residual
confounding (9).
Measures of central obesity, such as waist circumference
(WC) and waist-hip ratio (WHR), might help to better
assess body fat distribution in CAD patients. However, data
regarding the effect of central obesity on mortality in
patients with CAD are scant. Furthermore, the prognostic
value of central obesity in subjects with CAD and normal
BMI is unknown. Thus, we hypothesized that the “obesity
paradox” would not be observed if measures of central
obesity were used to assess outcomes in people with CAD,
instead of BMI.
To this end, the aims of this project were: 1) to conduct
a systematic review of the published data on studies assess-
ing the association between measures of abdominal obesity
(WC and WHR) and mortality in people with CAD; 2) to
determine the independent and incremental prognostic
information of measures of central obesity on mortality in
people with CAD and also specifically in those with normal
BMI; and 3) to calculate the risk of mortality attributable to
measures of central obesity.
Methods
Systematic review: search strategy. We searched the
OVID/Medline, EMBASE, CENTRAL, and Web of Sci-
ence databases from January 1980 to October 2008 for studies
that reported the association of either WC or WHR with
mortality in patients with established CAD.
Terms used in the search included words related to
measures of abdominal obesity (obesity, hip or trunk or
abdominal or waist and girth or circumference or ratio,
aist-hip ratio, body composition, body fat distribution, adipose
issue, abdominal fat, intra-abdominal fat, anthropometry,
runk, or visceral or central or abdominal and fat or obesity or
adipose); terms related to mortality (mortality, survival,
death, outcomes); and presence of CAD (coronary disease,
myocardial infarction, myocardial revascularization, CABG,
coronary bypass, coronary catheterization, percutaneous coronary
intervention). The search was limited to Medical Subject
Headings fields labeled as comparative studies, evaluation
studies, meta-analyses, multicenter studies, randomized
Abbreviations
and Acronyms
BMI  body mass index
CAD  coronary artery
disease
CI  confidence interval
HF  heart failure
HR  hazard ratio
WC  waist circumference
WHR  waist-hip ratiocontrolled trials, cohort studies, and follow-up studies.Inclusion criteria. Inclusion criteria were prospective co-
hort studies in which all reported subjects had: 1) CAD at
baseline (defined as a previous history of myocardial infarc-
tion, percutaneous coronary intervention, and/or coronary
artery bypass grafting); 2) measures of either WC or WHR;
3) mortality data on the basis of measures of WC or WHR;
and 4) minimum follow-up of 6 months.
Two investigators (T.C. and D.C.S.) independently re-
viewed all titles and abstracts of the studies identified
through the screening search, to determine eligibility. Once
potentially relevant abstracts were identified, the same
investigators independently read the selected studies in
entirety to determine whether they met inclusion criteria,
selecting the final studies that met eligibility criteria to enter
the analysis. There was 100% agreement between the 2
investigators.
One author (T.C.) contacted the authors of all of the
eligible studies by either e-mail or letter requesting subject-
level data from their respective studies. We also asked
experts in the field for unpublished data that might fulfill
inclusion criteria and included unpublished data from the
Mayo Clinic Cardiovascular Rehabilitation Program data-
base, for patients meeting the same eligibility criteria de-
scribed in the preceding text.
The use of the Mayo Clinic Cardiovascular Rehabilita-
tion Database in this study was approved by the Mayo
Clinic Institutional Review Board. The studies included in
this analysis also received approval from their respective
institutional review boards.
Definition of variables of interest. Our predictor variables
were WC, WHR, a unified variable for central obesity, and
BMI. Body mass index was defined as the weight (in
kilograms) divided by the square of height (in meters).
Abnormal WC and WHR were defined with clinically
acceptable standard cutoffs. High WC was defined by
National Cholesterol Education Program Adult Treatment
Panel III cutoffs of 88 cm for women and 102 cm for
men (10); high WHR was defined on the basis of World
Health Organization criteria as 0.85 for women and
0.90 for men (11). Furthermore, we also classified subjects
on the basis of sex-specific tertiles for BMI, WC, and
WHR. Because 1 study had no information on WC and
another had no information on WHR, we created a variable
called central obesity, which included either WC or WHR,
whichever was available. If both were available, we prefer-
entially used WHR because WHR is a specific measure of
fat distribution (“apple shape” vs. “pear shape”), which could
not be inferred from measuring WC alone.
For the BMI calculation, weight was measured with a
standard balance beam scale in all studies. The WC was
measured between the iliac crest and the lower ribs at a level
that had the minimum circumference in 4 studies and at the
level of the navel in 1 study. Hip circumference was
measured horizontally over the greatest posterior extension
of the buttocks in 3 studies and at the level of the major
trochanter in 1 study. The WHR was calculated by dividing
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May 10, 2011:1877–86 Central Obesity and Mortality in CADthe waist circumference by the hip circumference, both in
centimeters.
We created sex-specific BMI quintiles for the entire
cohort of subjects and also divided subjects into 5 categories
of BMI on the basis of clinically applicable standard cutoffs
(low BMI, if BMI 18.5 kg/m2; normal, if BMI was
between 18.5 and 24.9 kg/m2; overweight, if BMI was 25 to
9.9 kg/m2; obesity, if BMI was 30 to 34.9 kg/m2; and
besity grade II was defined as BMI 35 kg/m2).
Statistical analysis. Continuous variables were presented
as mean  SD. Heterogeneity was assessed with the
chi-square test with the RevMan software (version 4.2, The
Nordic Cochrane Centre, The Cochrane Collaboration
Copenhagen, Denmark), and a p value  0.05 was consid-
ered significant. We created Cox-proportional hazards
models to determine the independent association of tertiles
of WC, WHR, central obesity and BMI, and sex-specific
quintiles of BMI with mortality after adjusting for potential
confounders. Models were also created to determine the
association between groups on the basis of clinically appli-
cable cutoffs of WC, WHR, and BMI with mortality.
Covariates included in all the models were those that have
been shown to predict survival in cohorts of subjects with
CAD. We were limited to variables that were available for
most individuals across all of the cohorts included in the
pooled analysis (age, sex, history of smoking, diabetes,
hypertension, and heart failure [HF]). Additionally, models
assessing WC, WHR, or central obesity were adjusted for
BMI. Models using BMI were adjusted for central obesity.
The demographic differences among tertiles of WC, WHR,
and BMI were assessed with chi-square analysis for cate-
gorical variables and with 1-way analysis of variance for
continuous variables.
Subgroup analyses (adjusted for the aforementioned con-
founders) for men versus women, younger versus older than
65 years of age, smokers versus nonsmokers, and diabetic
versus nondiabetic persons were performed to assess the
effect of 1-SD increase in WC, WHR, or BMI on mortal-
ity. Furthermore, we tested the interaction between the
central obesity exposures and each of the following covari-
ates: sex, age, smoking, and presence of diabetes.
We created new tertiles of WC, WHR, and central
obesity for subjects with normal BMI and for subjects with
BMI 30 kg/m2. We created Cox-proportional hazards
odels as described in the survival analysis for the whole
ample. Furthermore, we assessed whether measuring both
C and WHR provided incremental prognostic informa-
ion. To this end, individuals were categorized into 4 groups
ccording to the clinical cutoffs for WC and WHR: low
C with low WHR (reference), high WC with low WHR,
ow WC with high WHR, and high WC with high WHR.
e also assessed the correlation among BMI, WC, and
HR with simple linear correlation in different pairs of
hese measures and tested the concordance between tertiles
f WC and tertiles of WHR with kappa statistics. If the
esults showed that WC and WHR were not strongly dorrelated/concordant, we assumed there would not be
ignificant collinearity. This would validate the inclusion of
oth variables in the model to evaluate the association of
oth measures of central obesity with mortality indepen-
ently of each other. To evaluate whether follow-up time
ad an impact in the overall results, we performed hazard
odels truncating the follow-up time to (6 months) while
ncorporating the same covariates used in the main models.
he SPSS software (version 15.0, SPSS, Inc., Chicago,
llinois) was used for statistical analysis.
To determine how many deaths could be attributed to
easures of central obesity in people with CAD, we
alculated the attributable risk of mortality to central obesity
ith a previously validated formula (12).
esults
ublished data search and data collection. After the
ublished data search, we identified 2,188 potentially rele-
ant abstracts, of which 6 met the inclusion criteria (13–18).
etails of the study selection process are outlined in Figure 1.
After the lead authors of the 6 eligible studies were
ontacted, 4 agreed to share de-identified individual subject
ata from their respective studies (14–16,18). We pooled
npublished data from the Mayo Clinic Cardiovascular
ehabilitation Cohort and constituted our final dataset for
nalysis (total of 5 studies included). Further details about
ach of the studies included are reported in Table 1.
ndividuals with missing data on height or weight were
xcluded, leaving 15,923 participants for the final analysis.
Of the 5 included studies, 3 had information on both
C and WHR. One had data on WC but not on WHR,
nd another study had WHR data but no information on
C. The WC and WHR were available in 14,284 and
2,836 subjects, respectively. We excluded 1 patient with
rroneous WHR measurement and 2 patients with errone-
us WC measurement. Heterogeneity analysis showed that
he effects of each individual study were not heterogeneous
ith respect to results on the basis of measures of central
besity (I2  0%, p  0.41) or on the basis of BMI (I2 
5%, p  0.19). The results of each individual study and in
he pooled sample are summarized in Figure 2.
ample characteristics. Descriptive characteristics of the
5,923 subjects are presented in Table 2. Mean  SD age
as 65.7  11.5 years, and 59% were men. The percentage
f subjects with a history of diabetes, hypertension, and HF
as significantly higher in the highest tertile of central
besity (Table 2). From the pooled data of 15,923 subjects,
,648 comprised the “Normal Weight” group (BMI: 18.5 to
4.9 kg/m2), whereas 2,396 comprised the “Obese” group
BMI 30 kg/m2). Duration of follow-up was different
mongst the studies and ranged from 6 months to 16 years.
edian (interquartile range) follow-up period for the pooled
ata was 2.3 (0.5 to 7.4) years, and there were 5,696 deaths.
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Central Obesity and Mortality in CAD May 10, 2011:1877–86Associations of different measures of obesity with mortality.
Cutoff values for tertiles for men in the whole cohort were:
WC: second tertile 89 cm, third tertile 99 cm; WHR:
second tertile 0.94, third tertile 0.98; BMI (in kg/m2):
econd tertile 24.1, third tertile 27.1. For women, cutoff
alues were: WC: second tertile 84 cm, third tertile 96 cm;
HR: second tertile 0.86, third tertile 0.93; BMI (in
2
Figure 1 Systematic Review and Article Selection
Flowchart outlining the published data search and exclusion of articles, leading to
CAD  coronary artery disease; WC  waist circumference; WHR  waist-hip ratiog/m ): second tertile 23.7, third tertile 27.9.A direct and statistically significant association with
mortality was noted for the second and third tertiles of
measures of central obesity after adjustment for age, sex,
smoking, diabetes, hypertension, HF, and BMI (Fig. 3).
In the multivariable model using central obesity cutoffs,
high WHR (hazard ratio [HR]: 1.69; 95% confidence
interval [CI]: 1.55 to 1.84) and high WC (HR: 1.29; 95%
al studies included in the analysis.the fin
.CI: 1.20 to 1.39) were significantly associated with
BMI  body mass index; CABG  coronary artery bypass grafting; CAD  coronary artery disease; MI  myocardial infarction; PCI  percutaneous coronary intervention; STEMI  ST-segment elevation
myocardial infarction; WC  waist circumference; WHR  waist-hip ratio.
1881JACC Vol. 57, No. 19, 2011 Coutinho et al.
May 10, 2011:1877–86 Central Obesity and Mortality in CADFigure 2 Mortality on the Basis of Tertiles of Central and Total Obesity, Stratified by Study and in the Pooled Sample
The analysis for each individual study was performed with study-specific tertiles, and the “total” row shows the results on the basis of tertiles
of the pooled sample with individual subject data. BMI  body mass index; CI  confidence interval.Characteristics of the Included StudiesTable 1 Characteristics of the Included Studies
First Author (Ref. #) Origin
Characteristics
of CAD Enrollment
No. of Subjects
(% Women)
Follow-Up
(Months),
Mean  SD Deaths, n Main Results
Kanaya et al. (14) United States MI, CABG, PCI, or
angiographic
occlusion
50% of
1 coronary
arteries
1993–1994 2,739 (100%) 81.6 4.8 498 Increasing WC was directly
related to higher mortality,
whereas BMI exhibited a
“U-shaped” association with
mortality.
Kragelund et al. (15) Denmark Acute myocardial
infarction
1990–1992 6,676 (33%) 73.8 57.5 4,534 Men in the upper quartile of WHR
had increased mortality
compared with the lowest
quartile, but the association
was not significant in women.
There was no association of
BMI with mortality.
Zeller et al. (16) France Acute myocardial
infarction
2001–2007 2,229 (27%) Median
12 months
301 WC and BMI were not
independent predictors of
death, but subjects with
normal BMI and high WC had
increased mortality.
Lee et al. (18) Korea STEMI 2005–2006 3,734 (26%) 6.6 1.0 175 Increasing WHR was directly
associated with higher
mortality, whereas increasing
BMI was inversely associated
with mortality.
Mayo Clinic Cardiovascular
Rehabilitation cohort
Rochester, MN MI, CABG, PCI, or
known history
of CAD
1993–2007 1,038 (20%) 104 44 188 Unpublished data
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Central Obesity and Mortality in CAD May 10, 2011:1877–86increased mortality. In contrast, increasing tertiles of
BMI were inversely associated with mortality (Fig. 3).
This association persisted even after using 5 sex-specific
BMI groups on the basis of BMI cutoffs. With normal
BMI as reference, the adjusted HRs were: BMI 18.5
kg/m2: 1.78 (95% CI: 1.53 to 2.01); BMI 25 to 29.9
g/m2: 0.84 (95% CI: 0.79 to 0.89); BMI 30 to 34.99
g/m2: 0.75 (95% CI: 0.69 to 0.82); and BMI 35
kg/m2: 0.78 (95% CI: 0.67 to 0.91). Similar results were
een after dividing the groups into 5 quintiles and also
ithout adjusting for central obesity in multivariable
odels assessing BMI (data not shown).
Results of the subgroup analyses showed that a 1-SD
ncrease of WC and of WHR was associated with higher
ortality, whereas a 1-SD increase of BMI was associated
ith lower mortality across all subgroups (Fig. 4). A
ignificant interaction was only found between sex and
ertiles of central obesity (p  0.001) and smoking and
ertiles of central obesity (p  0.02) for mortality.
In subjects with normal weight, the cutoff values used for
efinition of the tertiles in men were: WC: second tertile 84
m, third tertile 90 cm; WHR: second tertile 0.92, third
ertile 0.97; BMI (in kg/m2): second tertile 22.2, third
ertile 23.8. In women, cutoffs were: WC: second tertile 78
m, third tertile 85.5 cm; WHR: second tertile 0.85, third
ertile 0.92; BMI (in kg/m2): second tertile 21.6, third
ertile 23.4. Increasing tertiles of central obesity, WHR, and
C were also significantly associated with higher mortality
Fig. 3).
In obese individuals with CAD, the cutoff values used to
efine the tertiles in men were: WC: second tertile 107 cm,
hird tertile 115 cm; WHR: second tertile 0.98, third tertile
.03; BMI (in kg/m2): second tertile: 31.1, third tertile 32.8.
n women, cutoffs were: WC: second tertile 101 cm, third
ertile 110 cm; WHR: second tertile 0.87, third tertile
.95; BMI (in kg/m2): second tertile 31.9, third tertile
5.2. We again observed that WC, WHR, and central
besity were directly associated with mortality, whereas
MI was inversely associated with mortality in men and
omen (Fig. 5).
When follow-up time was truncated at 6 months,
esults were similar to the overall findings of the study,
uggesting that time of follow-up was not a major effect
odifier.
The factorial analysis showed that individuals with a high
C as well as high WHR had the highest mortality risk
Table 3). Similar results were found in normal weight
ubjects (Table 3).
ttributable risk to central obesity. The combined attrib-
table mortality risk for the second and third tertiles of
entral obesity in the whole cohort was 30.8% (43.2% in
omen, 19.4% in men). Among normal weight subjects, the
ttributable risk for central obesity was 33.1% (51.5% in
women, 19.9% in men).De T A W S H H H C H H W W B Va
lu A
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This study represents a collaborative effort to assess the
prognostic value of central obesity in individuals with CAD
by gathering data from 3 continents and over 15,000
subjects, therefore representing the largest analysis on this
subject. Our study shows several key findings: 1) increasing
central obesity was associated with higher mortality in
subjects with CAD, and central obesity shares a signifi-
cant attributable risk in this population; 2) BMI, a measure
of total adiposity, was inversely associated with mortality;
3) increasing central obesity was also associated with higher
mortality in obese individuals and in those with normal
BMI; 4) the prognostic impact of central obesity on mor-
tality in CAD patients is demonstrable in different sub-
Figure 3 Mortality on the Basis of Tertiles of Measures of Cen
HR  hazard ratio; other abbreviations as in Figures 1 and 2.groups of subjects; and 5) subjects with CAD who hadabnormal WC and WHR had higher mortality than those
with an abnormality in only 1 of the parameters.
First, our finding that central obesity is associated with
higher mortality in subjects with CAD mirrors the results of
meta-analyses of central obesity and incidence of cardiovas-
cular events in healthy subjects (19,20). A potential mech-
anism underlying this association is that adipose tissue
interacts closely with vascular function, inflammatory path-
ways, sympathetic activation, and renin–angiotensin–
aldosterone systems. It also contributes to insulin resistance
and hypertension (21). Central obesity correlates closely
with excessive visceral fat, which is associated with insulin
resistance, hypertriglyceridemia, highly atherogenic small
LDL particles, and low HDL levels, features considered
pro-atherogenic (22). Furthermore, visceral fat also seems to
nd Total Obesitytral aplay a role in inflammation (23), and has been found to be
1884 Coutinho et al. JACC Vol. 57, No. 19, 2011
Central Obesity and Mortality in CAD May 10, 2011:1877–86a direct link between obesity and hypertension (24). There-
fore, the heightened inflammatory state, coupled with a
more atherogenic lipid profile and hypertension might lead
to an excess of clinical cardiovascular events in individuals
with visceral and central obesity, regardless of their weight.
Second, our study also showed that a measure of total
adiposity (BMI) was inversely associated with mortality in
CAD patients. Although the relationship between increas-
ing BMI and mortality in the general population has been
demonstrated (4,25), this association seems to be more
complex in subjects with CAD. We have previously re-
Figure 4 Mortality on the Basis of Measures of Obesity in Diffe
Adjusted hazard ratios for mortality in different subgroups defined a priori accordin
Abbreviations as in Figures 1 and 2.
Figure 5 Mortality on the Basis of Tertiles of Measures of Cen
Abbreviations as in Figures 1 and 2.ported that overweight and obese individuals, who represent
the majority of people with myocardial infarction, have
lower mortality rates as compared with subjects with normal
BMI (26). In a meta-analysis of 40 studies, we found that
although underweight CAD subjects had increased mortal-
ity compared with those with normal BMI, overweight
individuals had lower mortality, and obese subjects had no
increase in mortality (7). Although the obesity paradox has
been attributed to residual confounding, the results of the
present analysis suggest that other possible explanations
need to be considered, because factors acting as confounders
Subgroups
-SD increase in different measures of central and total obesity.
nd Total Obesity in Obese Subjects (BMI >30 kg/m2)rent
g to 1tral a
s
e
a
ex as co
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May 10, 2011:1877–86 Central Obesity and Mortality in CADbetween low body weight and mortality would be expected
to affect measures of central obesity as well.
A potential explanation for this obesity paradox is that
BMI seems to be a poor marker of general adiposity, given
its inability to discriminate between fat and lean mass,
particularly in individuals with intermediate BMI values
(27). In the general population, a BMI 30 kg/m2 was
hown to have good specificity but poor sensitivity to detect
xcess body fatness (28). Body mass index values between 25
nd 29 kg/m2 failed to detect excess fat mass in approxi-
mately 50% of people (28), and BMI was also shown to have
poor diagnostic accuracy in people with CAD (27). By
contrast, the aforementioned concept has been recently
challenged by Lavie et al. (29), who demonstrated an inverse
relationship not only between BMI and mortality but also
between body fat percentage and mortality in CAD pa-
tients. These results, along with the results of our analysis
suggest that the association between fatness and mortality is
complex and might rely more on measures of fat distribution
than on the amount of body fat.
The third finding from our study is that central obesity is
associated with higher mortality even in individuals with
normal BMI. To the best of our knowledge, this is the first
study to identify the adverse prognosis associated with
central obesity in subjects with CAD and normal weight.
These findings might have significant implications for
clinical practice, because it is generally accepted that, if BMI
is normal, no further measures of obesity are necessary, and
no lifestyle modifications to induce weight loss might be
recommended. Similarly, WC, WHR, and central obesity
remained independent predictors of higher mortality in
people with BMI in the obese category, suggesting that
measures of central obesity are stronger prognostic markers
than BMI in CAD patients, irrespective of BMI. In light of
these results, we suggest that WC and/or WHR should be
documented in patients with CAD, regardless of their BMI,
to improve risk stratification and foster therapeutic recom-
mendations for fat loss.
Our results also indicate that the combination of abnor-
mal WC and WHR, present in over 20% of subjects, is
associated with the highest mortality risk in the whole
cohort and in subjects with normal BMI. Lastly, in our
cohort, central obesity alone explained approximately 30%
Adjusted Analysis of the Potential Additive Effects of WC and WHREntire Cohort and for Subjects With Normal W ightTable 3 Adju ted Analysi of e Potential Additive Effects of WEntire Cohort and for Subjects With Normal Weight
Whole Cohort
Group n HR (95% CI)
Low WC  Low WHR 2,056 1.00 (Reference)
Low WC  High WHR 5,838 1.41 (1.28–1.56)
High WC  Low WHR 361 1.11 (0.87–2.11)
High WC  High WHR 3,597 1.75 (1.57–1.95)
Adjustment included age, sex, smoking, hypertension, diabetes, heart failure, and body mass ind
Abbreviations as in Table 1.of all deaths, underscoring the importance of assessing bodyfat distribution and implementing weight loss strategies that
might increase survival.
The strengths of our study include the use of individual-
level data from a large cohort of subjects from 3 different
continents and with different manifestations of CAD to
directly compare the mortality risk of measures of central
(WC and WHR) and total adiposity (BMI) not only in the
entire sample but also in the subset of patients with normal
and elevated BMI.
The main shortcoming of our study was the lack of
uniform data on some variables that might be relevant in
survival analyses of CAD patients. However, we believe that
we have adequately adjusted our models for the main factors
that might lead to cardiovascular events in CAD, as shown
in the Framingham risk prediction model for secondary
events (30). It is also possible that the impact of central
obesity might be different for different ethnic groups, but
our data on ethnicity were not complete enough to perform
race-specific analyses.
Conclusions
Central obesity is directly associated with higher mortality
in individuals with CAD, whereas the opposite is observed
with BMI. The effect of central obesity on mortality is
observed even in subjects with normal BMI. Our data
suggest WC and WHR to be more reliable than BMI in
stratifying mortality risk in CAD patients, and WC and/or
WHR should be documented in individuals with CAD and
normal BMI for better risk stratification and therapeutic
considerations.
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